TMO in the 13F filings
Thermo Fisher Scientific Inc · CUSIP 883556102
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 25 Jul 2024
- Managers listing it
- 38
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 24 listed it in both
- Shares listed
- 55,403,800
- combined, among listed positions
- Reported value
- $30.6bn
- combined, at the quarter end
Among the 94 comparable managers: 25 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing TMO in Q2 2024
38 of 38 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Advisers LPexisting position · 378,700 shares now+337,100
- Point72 Asset Management LPexisting position · 336,537 shares now+296,646
- Two Sigma Investments LPexisting position · 427,815 shares now+274,898
- Renaissance Technologies LLCnew position · 235,849 shares now+235,849
- Invesco Ltdexisting position · 1,476,548 shares now+144,348
Reductions
- Capital World Investorsexisting position · 9,518,436 shares now-3,975,416
- MFS Investment Managementexisting position · 3,831,532 shares now-475,613
- Janus Henderson Group Ltdexisting position · 984,058 shares now-339,005
- Fidelity (FMR LLC)existing position · 6,583,006 shares now-334,967
- AllianceBernstein LPexisting position · 1,678,877 shares now-174,177
New positions and exits
New (6)
Exited (5)
- TCI Fund Management Ltdwas $882m
- Viking Global Investors LPwas $75m
- Steadfast Capital Management LPwas $32m
- Moore Capital Management LPwas $17m
- Maverick Capital Ltdwas $435k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 19 | $8.8bn | n.a. | n.a. |
| Q3 2013 | 19 | $10.1bn | n.a. | n.a. |
| Q4 2013 | 19 | $12.6bn | n.a. | n.a. |
| Q1 2014 | 22 | $12.8bn | n.a. | n.a. |
| Q2 2014 | 22 | $12.9bn | n.a. | n.a. |
| Q3 2014 | 22 | $13.6bn | n.a. | n.a. |
| Q4 2014 | 30 | $14.7bn | n.a. | n.a. |
| Q1 2015 | 27 | $15.0bn | n.a. | n.a. |
| Q2 2015 | 27 | $14.1bn | n.a. | n.a. |
| Q3 2015 | 20 | $13.5bn | n.a. | n.a. |
| Q4 2015 | 21 | $15.4bn | n.a. | n.a. |
| Q1 2016 | 21 | $14.7bn | n.a. | n.a. |
| Q2 2016 | 20 | $14.9bn | n.a. | n.a. |
| Q3 2016 | 18 | $15.7bn | n.a. | n.a. |
| Q4 2016 | 31 | $13.2bn | n.a. | n.a. |
| Q1 2017 | 27 | $13.8bn | n.a. | n.a. |
| Q2 2017 | 29 | $15.7bn | n.a. | n.a. |
| Q3 2017 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2017 | 20 | $18.2bn | n.a. | n.a. |
| Q1 2018 | 28 | $20.1bn | n.a. | n.a. |
| Q2 2018 | 27 | $19.9bn | n.a. | n.a. |
| Q3 2018 | 27 | $23.6bn | n.a. | n.a. |
| Q4 2018 | 30 | $21.6bn | n.a. | n.a. |
| Q1 2019 | 30 | $27.4bn | n.a. | n.a. |
| Q2 2019 | 33 | $28.8bn | n.a. | n.a. |
| Q3 2019 | 26 | $27.9bn | n.a. | n.a. |
| Q4 2019 | 26 | $30.3bn | n.a. | n.a. |
| Q1 2020 | 27 | $25.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $32.6bn | n.a. | n.a. |
| Q3 2020 | 29 | $38.9bn | n.a. | n.a. |
| Q4 2020 | 33 | $39.2bn | n.a. | n.a. |
| Q1 2021 | 35 | $36.5bn | n.a. | n.a. |
| Q2 2021 | 33 | $38.3bn | n.a. | n.a. |
| Q3 2021 | 32 | $42.6bn | n.a. | n.a. |
| Q4 2021 | 38 | $50.1bn | n.a. | n.a. |
| Q1 2022 | 32 | $43.2bn | n.a. | n.a. |
| Q2 2022 | 33 | $38.9bn | n.a. | n.a. |
| Q3 2022 | 26 | $34.3bn | n.a. | n.a. |
| Q4 2022 | 29 | $37.0bn | n.a. | n.a. |
| Q1 2023 | 35 | $37.1bn | n.a. | n.a. |
| Q2 2023 | 39 | $33.5bn | n.a. | n.a. |
| Q3 2023 | 39 | $32.6bn | n.a. | n.a. |
| Q4 2023 | 41 | $32.7bn | 19 | 23 |
| Q1 2024 | 30 | $34.1bn | 14 | 18 |
| Q2 2024 | 38 | $30.6bn | 25 | 18 |
| Q3 2024 | 30 | $33.8bn | 12 | 19 |
| Q4 2024 | 36 | $27.6bn | 22 | 15 |
| Q1 2025 | 31 | $24.2bn | 12 | 22 |
| Q2 2025 | 39 | $18.8bn | 27 | 11 |
| Q3 2025 | 32 | $21.9bn | 22 | 13 |
| Q4 2025 | 32 | $29.9bn | 27 | 20 |
| Q1 2026 | 34 | $24.4bn | 23 | 23 |
| Q2 2026 | 36 | $26.4bn | 27 | 22 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TMO and LLY →TMO and JNJ →TMO and VRTX →Choose a stock to compare with TMO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TMO, latest filings →Back to the 13F Explorer →